repaglinide has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christensen, MS; Hatorp, V; Haug-Pihale, G; Walther, KH | 1 |
| Hatorp, V | 1 |
1 review(s) available for repaglinide and Liver Dysfunction
| Article | Year |
|---|---|
Clinical pharmacokinetics and pharmacodynamics of repaglinide.
Topics: Adult; Aged; Blood Glucose; Carbamates; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Hypoglycemic Agents; Liver Diseases; Male; Piperidines; Renal Insufficiency; Rifampin | 2002 |
1 trial(s) available for repaglinide and Liver Dysfunction
| Article | Year |
|---|---|
Single-dose pharmacokinetics of repaglinide in subjects with chronic liver disease.
Topics: Adult; Blood Glucose; Blood Proteins; Caffeine; Carbamates; Chronic Disease; Humans; Hypoglycemic Agents; Liver Diseases; Male; Middle Aged; Piperidines; Protein Binding | 2000 |